SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-063713
Filing Date
2024-03-08
Accepted
2024-03-08 16:42:09
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d802031ds3.htm S-3 278822
2 EX-4.9 d802031dex49.htm EX-4.9 290242
3 EX-5.1 d802031dex51.htm EX-5.1 24155
4 EX-23.3 d802031dex233.htm EX-23.3 1741
5 EX-FILING FEES d802031dexfilingfees.htm EX-FILING FEES 69991
6 GRAPHIC g802031dsp95.jpg GRAPHIC 6345
7 GRAPHIC g802031dsp96.jpg GRAPHIC 3923
8 GRAPHIC g802031g25x78.jpg GRAPHIC 63153
  Complete submission text file 0001193125-24-063713.txt   767648
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277795 | Film No.: 24735104
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)